This opinion cites 26 cases:
in-re-tamoxifen-citrate-antitrust-litigation-joblove-allied-servs-div , 429 F.3d 370 ( 2005 )
purepac-pharmaceutical-company-v-tommy-g-thompson-secretary-of-health , 354 F.3d 877 ( 2004 )
Winner International Royalty Corporation v. Ching-Rong Wang , 202 F.3d 1340 ( 2000 )
In Re Wayne O. Johnson , 747 F.2d 1456 ( 1984 )
Yamanouchi Pharmaceutical Co., Ltd. And Merck & Co., Inc. v. Danbury Pharmacal, Inc., Schein Pharmaceutical, Inc., and Marsam Pharmaceuticals, Inc. , 231 F.3d 1339 ( 2000 )
Akron Polymer Container Corporation, and Robert Winer, Counterdefendant v. Exxel Container, Inc. , 148 F.3d 1380 ( 1998 )
Ecolochem, Inc. v. Southern California Edison Company , 227 F.3d 1361 ( 2000 )
Syntex (u.s.a.) LLC and Allergan, Inc. v. Apotex, Inc., Apotex Corp., and Novex Pharma , 407 F.3d 1371 ( 2005 )
Merck & Co., Inc. v. Danbury Pharmacal, Inc. , 873 F.2d 1418 ( 1989 )
In Re Eli Lilly & Company , 902 F.2d 943 ( 1990 )
Refac International, Ltd. And Forward Reference Systems, Ltd. v. Lotus Development Corporation , 81 F.3d 1576 ( 1996 )
Hoffmann-La Roche, Inc., and Roche Molecular Systems, Inc. v. Promega Corporation , 323 F.3d 1354 ( 2003 )
perseptive-biosystems-inc-v-pharmacia-biotech-inc-pharmacia-biotech , 225 F.3d 1315 ( 2000 )
Richardson-Vicks Inc. v. The Upjohn Company, Defendant/cross-Appellant, and McNeil Inc. And Johnson & Johnson , 122 F.3d 1476 ( 1997 )
Ultra-Tex Surfaces, Inc. And Dryvit Systems, Inc. v. Hill Brothers Chemical Co. And Omega Products Corp., Defendants-Cross and Vincent Chacon , 204 F.3d 1360 ( 2000 )
Knoll Pharmaceutical Company, Inc. And the John and Lois Arnold Family Limited Liability Partnership v. Teva Pharmaceuticals Usa, Inc. , 367 F.3d 1381 ( 2004 )
Glaxo Group Limited and Smithkline Beecham Corp. v. Apotex, Inc. , 376 F.3d 1339 ( 2004 )
In Re Patrick H. O'farrell, Barry A. Polisky and David H. Gelfand , 853 F.2d 894 ( 1988 )
Molins Plc, and John Coventry Smith, Jr. v. Textron, Inc., Kearney & Trecker Corporation, and Avco Corporation , 48 F.3d 1172 ( 1995 )
Merck & Co. v. Teva Pharmaceuticals USA , 395 F.3d 1364 ( 2005 )
